PledPharma
| Contact | Jan Olof G. Karlsson |
| Employees | 0-9 |
| Address | Teknikringen 7 583 30 Linköping |
| Telefon | 0733 - 30 46 24 |
| janolof.karlsson (at) pledpharma.se | |
| Website | www.pledpharma.se |
PledPharma develops new medicines that protects against dose-limiting side effects during cancer therapy with cytostatic drugs, without diminishing the anticancer effect. The medicine is based on Low Molecular weight Enzyme Mimetics (LowMEM). The company’s first candidate PP-095 is now being tested on cancer patients in clinical phase II trials.
